Press Enter or click the Search button above to view results.

Recent Drug Updates

  • olaparib (Lynparza) New indication, dose, and dosage form approved for maintenance treatment of recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer
  • spironolactone (CaroSpir) FDA approves first oral liquid dosage form of the potassium-sparing diuretic
  • cytarabine daunorubicin liposomal (Vyxeos) FDA approved a new fixed combination for newly diagnosed therapy-related acute myeloid leukemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC)